UNIVERSITY OF ARIZONA

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1885-01-01

Employees: 10K

Market Cap: -

Website: http://www.arizona.edu

Clinical Trials

Study Of Right Ventricular Performance In PAH Patients Treated With Rapid Dose Treprostinil (Remodulin)

Completed

Conditions: Pulmonary Arterial Hypertension

First Posted Date: 2014-02-28

Last Posted Date: 2016-11-17

Lead Sponsor: University of Arizona

Target Recruit Count: 15

Registration Number: NCT02074449

Locations: 🇺🇸
University of Arizona, Tucson, Arizona, United States

Cognitive Effects of Interferon in Patients With Melanoma

Completed

Conditions: Melanoma

Interventions: Biological: Interferon alpha

First Posted Date: 2014-02-28

Last Posted Date: 2014-02-28

Lead Sponsor: University of Arizona

Target Recruit Count: 36

Registration Number: NCT02074605

Locations: 🇺🇸
University of Arizona, Tucson, Arizona, United States

Vismodegib in Basal Cell Carcinomas (BCC) Chemoprevention

Phase 2

Terminated

Conditions: Basal Cell Carcinomas

Interventions: Drug: Placebo
Drug: Vismodegib

First Posted Date: 2014-02-20

Last Posted Date: 2019-08-14

Lead Sponsor: University of Arizona

Target Recruit Count: 9

Registration Number: NCT02067104

Locations: 🇺🇸
University of Arizona Cancer Center, Tucson, Arizona, United States

Combo of Abraxane, TMZ, Bevacizumab in Metastatic Melanoma With Brain Metastases

Phase 1

Withdrawn

Conditions: Brain Metastases
Metastatic Melanoma

Interventions: Drug: nab-paclitaxel
Drug: Temozolomide
Drug: Bevacizumab

First Posted Date: 2014-02-19

Last Posted Date: 2016-04-21

Lead Sponsor: University of Arizona

Registration Number: NCT02065466

Locations: 🇺🇸
Arizona Cancer Center at University of Arizona Health Sciences Center, Tucson, Arizona, United States
🇺🇸
University of Arizona Cancer Center, Tucson, Arizona, United States

The Brain on Whole Body Hyperthermia: A Neuroimaging Study

Not Applicable

Completed

Conditions: Major Depression

Interventions: Device: Low intensity whole-body infrared heating
Device: High intensity whole-body infrared heating
Device: Functional Magnetic Resonance Imaging (fMRI) and electrocardiogram (EKG)
Other: Questionnaires

First Posted Date: 2014-02-14

Last Posted Date: 2015-08-10

Lead Sponsor: University of Arizona

Target Recruit Count: 23

Registration Number: NCT02062840

Locations: 🇺🇸
University of Arizona, Tucson, Arizona, United States

Johrei Therapy and CBT-I in Facilitating Sleep in ICU Survivors

Not Applicable

Conditions: Sleep Disturbances in Survivors of Critical Illness

Interventions: Behavioral: Cognitive Behavioral Therapy for Insomnia (CBT-I)
Other: Johrei therapy

First Posted Date: 2014-02-11

Last Posted Date: 2018-08-07

Lead Sponsor: University of Arizona

Target Recruit Count: 50

Registration Number: NCT02059421

Locations: 🇺🇸
University of Arizona Medical Center, Tucson, Arizona, United States

Peer-Driven Intervention for Sleep Apnea

Not Applicable

Conditions: Obstructive Sleep Apnea

Interventions: Other: Usual Care
Other: Peer-Buddy System

First Posted Date: 2014-02-05

Last Posted Date: 2017-07-05

Lead Sponsor: University of Arizona

Target Recruit Count: 362

Registration Number: NCT02056002

Locations: 🇺🇸
University of Arizona Center for Sleep Disorders, Tucson, Arizona, United States

A Phase II Study of Vemurafenib Combined With Acitretin in Patients With Advanced Melanoma

Phase 2

Terminated

Conditions: Malignant Melanoma

Interventions: Drug: Acitretin
Drug: Vemurafenib

First Posted Date: 2014-01-30

Last Posted Date: 2018-12-26

Lead Sponsor: University of Arizona

Target Recruit Count: 2

Registration Number: NCT02050321

Locations: 🇺🇸
University of Arizona Cancer Center, Tucson, Arizona, United States

Virtual Reality-based Exercise in Older Adults

Not Applicable

Completed

Conditions: Distorted; Balance
Motor Deficit

Interventions: Other: Balance Training

First Posted Date: 2014-01-23

Last Posted Date: 2014-07-28

Lead Sponsor: University of Arizona

Target Recruit Count: 33

Registration Number: NCT02043834

Locations: 🇺🇸
Villa Hermosa - Senior Living Tucson, Tucson, Arizona, United States

Phase II Study of Metformin for Reduction of Obesity-Associated Breast Cancer Risk

Phase 2

Completed

Conditions: Breast Cancer Prevention

Interventions: Drug: Placebo
Drug: Metformin

First Posted Date: 2014-01-07

Last Posted Date: 2023-06-27

Lead Sponsor: University of Arizona

Target Recruit Count: 151

Registration Number: NCT02028221

Locations: 🇺🇸
University of Arizona, Tucson, Arizona, United States

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy